Oraverse is a Submucosal Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Septodont, Inc.. The primary component is Phentolamine Mesylate.
| Product ID | 0362-0101_f0465990-acce-46dc-9290-344dab1e4f2f |
| NDC | 0362-0101 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Oraverse |
| Generic Name | Phentolamine Mesylate |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBMUCOSAL |
| Marketing Start Date | 2011-06-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022159 |
| Labeler Name | Septodont, Inc. |
| Substance Name | PHENTOLAMINE MESYLATE |
| Active Ingredient Strength | 0 mg/mL |
| Pharm Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2011-06-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA022159 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2011-06-01 |
| Marketing Category | NDA |
| Application Number | NDA022159 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2011-06-01 |
| Marketing End Date | 2018-12-05 |
| Ingredient | Strength |
|---|---|
| PHENTOLAMINE MESYLATE | .235 mg/mL |
| SPL SET ID: | 4025cf98-ea87-4531-b0fc-6283c84f63f3 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0362-0101 | Oraverse | Phentolamine Mesylate |
| 0143-9564 | Phentolamine Mesylate | Phentolamine Mesylate |
| 51224-012 | Phentolamine Mesylate | Phentolamine Mesylate |
| 68094-101 | PHENTOLAMINE MESYLATE | PHENTOLAMINE MESYLATE |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ORAVERSE 77304442 3632280 Live/Registered |
SEPTODONT HOLDING 2007-10-15 |